Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
$149 a month new oral GLP-1 pill for weight loss (Foundayo (orforglipron)) now available in the US
European Commission approves Kygevvi (doxecitine and doxribtimine) as first and only treatment for thymidine kinase 2 deficiency
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
Cambridge’s grassroots life sciences showcase branches out to Oxford and London
Major growth in visitor numbers, full halls, clear future topics: Analytica 2026 sets standards
Interphex week Tokyo 2026 conference programme announced
Life sciences congress descends on Lisbon
© 2026 Pharma Press Publishing.
